English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/103752
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 23 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

Squalene Synthase As a Target for Chagas Disease Therapeutics

Autor Shang, N.; Li, Q.; Ko, T.-P.; Chan, H.-C.; Li, J.; Zheng, Y.; Huang, C.-H.; Ren, F.; Chen, C.-C.; Zhu, Z.; Galizzi, M.; Li, Z.-H.; Rodrigues-Poveda, C.A.; Gonzalez-Pacanowska,Dolores; Veiga-Santos, P.; de Carvalho, T.M.U.; de Souza, W.; Urbina, J.A.; Wang, A.H.-J.; Docampo, R.; Li, K.; Liu, Y.-L.; Oldfield, E.; Guo, R.-T.
Fecha de publicación 2014
EditorPublic Library of Science
Citación PLoS Pathogens 10 (2014)
ResumenTrypanosomatid parasites are the causative agents of many neglected tropical diseases and there is currently considerable interest in targeting endogenous sterol biosynthesis in these organisms as a route to the development of novel anti-infective drugs. Here, we report the first x-ray crystallographic structures of the enzyme squalene synthase (SQS) from a trypanosomatid parasite, Trypanosoma cruzi, the causative agent of Chagas disease. We obtained five structures of T. cruzi SQS and eight structures of human SQS with four classes of inhibitors: the substrate-analog S-thiolo-farnesyl diphosphate, the quinuclidines E5700 and ER119884, several lipophilic bisphosphonates, and the thiocyanate WC-9, with the structures of the two very potent quinuclidines suggesting strategies for selective inhibitor development. We also show that the lipophilic bisphosphonates have low nM activity against T. cruzi and inhibit endogenous sterol biosynthesis and that E5700 acts synergistically with the azole drug, posaconazole. The determination of the structures of trypanosomatid and human SQS enzymes with a diverse set of inhibitors active in cells provides insights into SQS inhibition, of interest in the context of the development of drugs against Chagas disease. © 2014 Shang, et al.
URI http://hdl.handle.net/10261/103752
DOI10.1371/journal.ppat.1004114
Identificadoresdoi: 10.1371/journal.ppat.1004114
issn: 1553-7374
Aparece en las colecciones: (IPBLN) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Squalene_Na_Shang.pdf4,94 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.